Increased cerebrospinal fluid calpain activity and microparticle levels in Alzheimer's disease

Alzheimer's and Dementia

Volumn 11, Issue 5, 2015, Pages 465-474

  Laske, Christoph ^a,b   Stellos, Konstantinos ^c   Kempter, Ingrid ^c   Stransky, Elke ^a   Maetzler, Walter ^a,b   Fleming, Ingrid ^c   Randriamboavonjy, Voahanginirina ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Calpain activity; CSF; Dementia; Microparticles; Plasma; Serum

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; CALPAIN; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; FLOW CYTOMETRY; MIDDLE AGED; NONPARAMETRIC TEST; PSYCHOLOGICAL RATING SCALE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOMARKERS; CALPAIN; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC; TAU PROTEINS;

EID: 84929175696     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.06.003     Document Type: Article

References (39)

1. J.L. Cummings Alzheimer's disease N Engl J Med 351 2004 56 67
2. S.B. De, R. Vassar, and T. Golde The secretases: enzymes with therapeutic potential in Alzheimer disease Nat Rev Neurol 6 2010 99 107
3. R. Vassar, D.M. Kovacs, R. Yan, and P.C. Wong The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential J Neurosci 29 2009 12787 12794
4. R.M. Holsinger, C.A. McLean, K. Beyreuther, C.L. Masters, and G. Evin Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease Ann Neurol 51 2002 783 786
5. R.M. Holsinger, J.S. Lee, A. Boyd, C.L. Masters, and S.J. Collins CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias Neurology 67 2006 710 712
6. H. Zetterberg, U. Andreasson, O. Hansson, G. Wu, S. Sankaranarayanan, and M.E. Andersson Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease Arch Neurol 65 2008 1102 1107
7. B. Liang, B.Y. Duan, X.P. Zhou, J.X. Gong, and Z.G. Luo Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease J Biol Chem 285 2010 27737 27744
8. D.E. Goll, V.F. Thompson, H. Li, W. Wei, and J. Cong The calpain system Physiol Rev 83 2003 731 801
9. X. Chen, T. Huang, J. Zhang, J. Song, L. Chen, and Y. Zhu Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons Brain Res 1200 2008 99 106
10. L. Gao, S. Tian, H. Gao, and Y. Xu Hypoxia increases Abeta-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice J Mol Neurosci 51 2013 138 147
11. R.A. Nixon, K.I. Saito, F. Grynspan, W.R. Griffin, S. Katayama, and T. Honda Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease Ann N Y Acad Sci 747 1994 77 91
12. K. Saito, J.S. Elce, J.E. Hamos, and R.A. Nixon Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration Proc Natl Acad Sci U S A 90 1993 2628 2632
13. M. Higuchi, N. Iwata, Y. Matsuba, J. Takano, T. Suemoto, and J. Maeda Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology FASEB J 26 2012 1204 1217
14. F. Raynaud, and A. Marcilhac Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease FEBS J 273 2006 3437 3443
15. R. Medeiros, M. Kitazawa, M.A. Chabrier, D. Cheng, D. Baglietto-Vargas, and A. Kling Calpain inhibitor A-705253 mitigates Alzheimer's disease-like pathology and cognitive decline in aged 3xTgAD mice Am J Pathol 181 2012 616 625
16. E. Lee, J.E. Eom, H.L. Kim, K.H. Baek, K.Y. Jun, and H.J. Kim Effect of conjugated linoleic acid, mu-calpain inhibitor, on pathogenesis of Alzheimer's disease Biochim Biophys Acta 1831 2013 709 718
17. R.C. Sinjoanu, S. Kleinschmidt, R.S. Bitner, J.D. Brioni, A. Moeller, and A. Ferreira The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons Neurochem Int 53 2008 79 88
18. H.R. Momeni Role of calpain in apoptosis Cell J 13 2011 65 72
19. M.A. Smith, and R.G. Schnellmann Calpains, mitochondria, and apoptosis Cardiovasc Res 96 2012 32 37
20. P.R. Siljander Platelet-derived microparticles - an updated perspective Thromb Res 127 Suppl 2 2011 S30 S33
21. J.G. Kelton, T.E. Warkentin, C.P. Hayward, W.G. Murphy, and J.C. Moore Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles Blood 80 1992 2246 2251
22. J.M. Pasquet, F. Toti, A.T. Nurden, and J. Dachary-Prigent Procoagulant activity and active calpain in platelet-derived microparticles Thromb Res 82 1996 509 522
23. V. Randriamboavonjy, J. Isaak, A. Elgheznawy, F. Pistrosch, T. Fromel, and X. Yin Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes Blood 120 2012 415 423
24. World Health Organization Tenth revision of the International Classification of Diseases. Chapter 5 (F): Mental and behavioural disorders (including disorders of psychological development). Clinical Descriptions and Diagnostic Guidelines 1992 World Health Organization Geneva
25. th ed 1994 American psychiatric Press Washington, D.C
26. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
27. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
28. P.S. Vosler, C.S. Brennan, and J. Chen Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration Mol Neurobiol 38 2008 78 100
29. T. Tapiola, I. Alafuzoff, S.K. Herukka, L. Parkkinen, P. Hartikainen, and H. Soininen Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain Arch Neurol 66 2009 382 389
30. H.T. Nguyen, D.R. Sawmiller, Q. Wu, J.J. Maleski, and M. Chen Evidence supporting the role of calpain in the alpha-processing of amyloid-beta precursor protein Biochem Biophys Res Commun 420 2012 530 535
31. S.Y. Park, and A. Ferreira The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration J Neurosci 25 2005 5365 5375
32. G.R. Watkins, N. Wang, M.D. Mazalouskas, R.J. Gomez, C.R. Guthrie, and B.C. Kraemer Monoubiquitination promotes calpain cleavage of the protein phosphatase 2A (PP2A) regulatory subunit alpha4, altering PP2A stability and microtubule-associated protein phosphorylation J Biol Chem 287 2012 24207 24215
33. S. Hosseinzadeh, M. Zahmatkesh, M.R. Zarrindast, G.R. Hassanzadeh, M. Karimian, and A. Sarrafnejad Elevated CSF and plasma microparticles in a rat model of streptozotocin-induced cognitive impairment Behav Brain Res 256 2013 503 511
34. F. Mobarrez, R. Nybom, V. Johansson, C.M. Hultman, H. Wallen, and M. Landen Microparticles and microscopic structures in three fractions of fresh cerebrospinal fluid in schizophrenia: case report of twins Schizophr Res 143 2013 192 197
35. Q.X. Li, S. Whyte, J.E. Tanner, G. Evin, K. Beyreuther, and C.L. Masters Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets Lab Invest 78 1998 461 469
36. K. Stellos, V. Panagiota, A. Kogel, T. Leyhe, M. Gawaz, and C. Laske Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients J Cereb Blood Flow Metab 30 2010 1817 1820
37. C.I. Prodan, E.D. Ross, J.A. Stoner, L.D. Cowan, A.S. Vincent, and G.L. Dale Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease Neurology 76 2011 247 252
38. C. Laske, T. Leyhe, E. Stransky, G.W. Eschweiler, A. Bueltmann, and H. Langer Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease J Psychiatr Res 42 2008 746 751
39. R.T. Wang, D. Jin, Y. Li, and Q.C. Liang Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease J Psychiatr Res 47 2013 644 649